↓ Skip to main content

Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth In Vivo

Overview of attention for article published in Frontiers in oncology, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth In Vivo
Published in
Frontiers in oncology, April 2022
DOI 10.3389/fonc.2022.852940
Pubmed ID
Authors

Daniel P. Radin, Gregory Smith, Victoria Moushiaveshi, Alexandra Wolf, Robert Bases, Stella E. Tsirka

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 8%
Student > Ph. D. Student 1 8%
Student > Bachelor 1 8%
Researcher 1 8%
Student > Master 1 8%
Other 0 0%
Unknown 7 58%
Readers by discipline Count As %
Unspecified 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Agricultural and Biological Sciences 1 8%
Unknown 9 75%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2023.
All research outputs
#8,855,792
of 26,166,431 outputs
Outputs from Frontiers in oncology
#3,508
of 22,913 outputs
Outputs of similar age
#170,126
of 452,864 outputs
Outputs of similar age from Frontiers in oncology
#227
of 1,558 outputs
Altmetric has tracked 26,166,431 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 452,864 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 1,558 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.